PPAR  attenuates intimal hyperplasia by inhibiting TLR4-mediated inflammation in vascular smooth muscle cells

Low molecular weight fucoidan prevents intimal hyperplasia in rat injured thoracic aorta through the modulation of matrix metalloproteinase-2 expression

(2010) Hanna Hlawaty et al.   BIOCHEMICAL PHARMACOLOGY

Impaired Peroxisome Proliferator-activated Receptor-γ Contributes to Phenotypic Modulation of Vascular Smooth Muscle Cells during Hypertension

(2010) Lili Zhang et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Pioglitazone Inhibits Toll-Like Receptor Expression and Activity in Human Monocytes and db/db Mice

(2009) Mohan R. Dasu et al.   ENDOCRINOLOGY

PPARγ agonist, rosiglitazone, regulates angiotensin II-induced vascular inflammation through the TLR4-dependent signaling pathway

(2009) Yuanyuan Ji et al.   LABORATORY INVESTIGATION

Mechanisms of Intimal Hyperplasia Learned from a Murine Carotid Artery Ligation Model

(2008) Le-Ning Zhang et al.   Current Vascular Pharmacology

High Glucose Induces Toll-Like Receptor Expression in Human Monocytes: Mechanism of Activation

(2008) M. R. Dasu et al.   DIABETES

Toll-like receptor 4 mediates cross-talk between peroxisome proliferator-activated receptor γ and nuclear factor-κB in macrophages

(2008) Brian M. Necela et al.   IMMUNOLOGY

The role of progenitor cells in the development of intimal hyperplasia

(2008) Shirling Tsai et al.   JOURNAL OF VASCULAR SURGERY

Innate immunity has a dual effect on vascular healing: Suppression and aggravation of neointimal formation and remodeling post-endotoxin challenge

(2007) H. Epstein et al.   ATHEROSCLEROSIS